Medtronic Diabetes shared new timeline hopes on its upcoming diabetes device pipeline at the JP Morgan Healthcare Conference on January 12. Notably, management expects to launch the MiniMed 640G/Enlite 3 CGM (predictive low glucose management) in the US by April 2016, and a hybrid closed loop system (one step closer to a fully automated ‘artificial pancreas’) – the MiniMed 670G – by April 2017!
Asserts MiniMed 640G w/ predictive hypo suspend by April 2016; hybrid closed loop by April 2017
Posted in Glucose & Insulin